CVR Med­i­cal ap­points Langston as sales, mar­ket­ing VP

Stockwatch Daily - - FRONT PAGE - Mr. Peter Bakema re­ports

CVR MED­I­CAL Corp. has added Alan Langston to the com­pany’s ex­ec­u­tive staff. M r . Langston as­sumes the po­si­tion of vice-pres­i­dent of sales and mar­ket­ing, re­spon­si­ble for cre­at­ing and im­ple­ment­ing mar­ket en­try strate­gies for the com­pany’s carotid stenotic scan (CSS) de­vice.

Mr. Langston brings with him a dec­o­rated his­tory across a broad spec­trum of the tech in­dus­try in the sales, mar­ket­ing and dis­tri­bu­tion chan­nels, work­ing with lead­ing global man­u­fac­tur­ers and orig­i­nal equip­ment man­u­fac­tur­ers such as Kon­tron Amer­ica, Pana­sonic, Ar­row Elec­tron­ics, Avnet, GE, Siemens and Philips, over­driv­ing sales fig­ures and widen­ing mar­ket shares for emerg­ing tech­nolo­gies. Dur­ing his ten­ure at Kon­tron Amer­ica, the sec­ond-lead­ing global em­bed­ded com­puter sup­plier, an­nual chan­nel sales fig­ures grew from $12-mil­lion to $41-mil­lion. While with Pana­sonic’s Tough­book divi­sion, Mr. Langston over­saw sim­i­lar re­sults, tak­ing a new ISV (in­de­pen­dent soft­ware ven­dor) group from nil to $4-mil­lion in new op­por­tu­ni­ties within 12 months.

Over the past decade, Mr. Langston has served as a con­sul­tant for CVR, be­com­ing well versed with the CSS de­vice and the car­dio­vas­cu­lar health care land­scape. As the CSS launch rapidly ap­proaches, he has opted to make a full-time com­mit­ment to CVR and its break­through suc­cess.

“There is such a strong, pas­sion­ate con­nec­tion be­tween what CVR is cre­at­ing and the de­sires of doc­tors and med­i­cal cen­tres for a bet­ter way to eval­u­ate and treat pa­tients with steno­sis,” Mr. Langston ex­plained. “Af­ter 10 years of con­sis­tently con­sult­ing with CVR and watch­ing this prod­uct evolve, I feel that ev­ery­thing is aligned per­fectly for both my­self and the com­pany to move for­ward to­gether. This is one of the most re­mark­able de­vices to be­come avail­able to the med­i­cal com­mu­nity in a long time.”

CVR chief ex­ec­u­tive of­fi­cer Peter Bakema shares the en­thu­si­asm for Mr. Langston’s join­ing. “Alan has been a part of our ad­vi­sory group that has helped us de­velop the CSS,” he stated. “That fa­mil­iar­ity, cou­pled with his ex­pe­ri­ence build­ing com­pre­hen­sive mar­ket­ing plans and bring­ing new tech­nolo­gies to mar­ket, is vi­tal to us. His ad­di­tion gives us con­tin­ued mo­men­tum to­ward the im­mi­nent launch of the CSS and con­fi­dence that it will be­gin to re­al­ize its po­ten­tial right out of the gate.”

“This is a prod­uct that peo­ple truly need,” said Mr. Langston. “As we de­velop strate­gies and build our dis­tri­bu­tion net­works, that will al­ways be at the core of our mes­sage. The best path to low­er­ing the im­pact and cost of stroke is pre­ven­tion, and CVR’s plan is to help the med­i­cal com­mu­nity do it in a way that is fast, ac­cu­rate and cost-ef­fec­tive. It isn’t a mat­ter of if or when; it’s hap­pen­ing now.”

About CVR Med­i­cal Corp.

CVR Med­i­cal is a com­pany that is in­volved in an equal-part joint ven­ture with CVR Global Inc. The joint ven­ture op­er­ates in the med­i­cal in­dus­try fo­cused on the com­mer­cial­iza­tion of a pro­pri­etary sub­sonic, in­fra­sonic and low-fre­quency sound wave anal­y­sis tech­nol­ogy and has patents to a di­ag­nos­tic de­vice de­signed to de­tect and mea­sure carotid ar­te­rial steno­sis.

We seek Safe Har­bor.

Ron­nie Floyd Birch, Paul S Blun­den, Bruno Chris­tian Fr­us­calzo, Dou­glas Weaver, Er­win Wong

(CVM) Shares: 61,513,033

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.